Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorGUFFON, Nathalie
dc.contributor.authorGENEVAZ, Delphine
hal.structure.identifierLaboratoire Maladies Rares: Génétique et Métabolisme (Bordeaux) [U1211 INSERM/MRGM]
dc.contributor.authorLACOMBE, Didier
hal.structure.identifierSanofi Gentilly [Sanofi Gentilly]
dc.contributor.authorLE PEILLET FEUILLET, Eliane
dc.contributor.authorBAUSSON, Pascale
hal.structure.identifierCentre Hospitalier Universitaire [Strasbourg] [CHU Strasbourg]
dc.contributor.authorNOEL, Esther
dc.contributor.authorMAILLOT, Francois
dc.contributor.authorBELMATOUG, Nadia
dc.contributor.authorJAUSSAUD, Roland
dc.date.accessioned2023-05-16T12:34:54Z
dc.date.available2023-05-16T12:34:54Z
dc.date.issued2022-12-23
dc.identifier.issn1750-1172en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/182157
dc.description.abstractEnMucopolysaccharidoses (MPS) are a group of inherited lysosomal storage diseases caused by defective enzyme activity involved in the catalysis of glycosaminoglycans. Published data on adult patients with MPS remains scarce. Therefore, the present qualitative survey study was aimed at understanding knowledge of the disease, unmet needs, expectations, care, and overall medical management of adult/adolescent patients with MPS I, II and VI and their caregivers in France. A total of 25 patients (MPS I, n = 11; MPS II, n = 9; MPS VI, n = 5) were included and about 36 in-depth interviews (caregivers alone, n = 8; patients-caregiver pair, n = 22; patients alone, n = 6) were conducted. Except one (aged 17 years), all patients were adults (median age: 29 years [17-50]) and diagnosed at median age of 4 years [0.4-30], with mainly mothers as caregivers (n = 16/19). Patients were classified into three groups: Group A, Patients not able to answer the survey question because of a severe cognitive impairment (n = 8); Group B, Patients able to answer the survey question with low or no cognitive impairment and high motor disability (n = 10); and Group C, Patients able to answer the survey question with low or no cognitive impairment and low motor disability (n = 7). All groups were assessed for impact of disease on their daily lives based on a scale of 0-10. Caregivers in Group A were found to be most negatively affected by the disease, except for professional activity, which was most significantly impacted in Group B (4.7 vs. 5.4). The use of orthopaedic/medical equipments, was more prevalent in Groups A and B, versus Group C. Pain management was one of the global unmet need expressed by all groups. Group A caregivers expected better support from childcare facilities, disability clinics, and smooth transition from paediatric care to adult medicine. Similarly, Group B caregivers expected better specialised schools, whereas Group C caregivers expected better psychological support and greater flexibility in weekly infusion schedules for their patients. The survey concluded that more attention must be paid to the psychosocial status of patients and caregivers. The preference for reference centre for follow-up and treatment, hospitalizations and surgeries were evident. The most significant needs expressed by the patients and caregivers include better understanding of the disease, pain management, monitoring of complications, flexibility in enzyme replacement therapy, home infusions especially for attenuated patients, and improved transitional support from paediatric to adult medicine.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enCaregiver
dc.subject.enDisability
dc.subject.enMucopolysaccharidoses
dc.subject.enQuality of life
dc.subject.enQualitative survey
dc.title.enUnderstanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey study.
dc.title.alternativeOrphanet J Rare Disen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1186/s13023-022-02593-2en_US
dc.identifier.pubmed36564803en_US
bordeaux.journalOrphanet Journal of Rare Diseasesen_US
bordeaux.page448-460en_US
bordeaux.volume17en_US
bordeaux.hal.laboratoriesMaladies Rares : Génétique et Métabolisme (MRGM) - UMR 1211en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDSanofien_US
bordeaux.import.sourcepubmed
hal.description.error<?xml version="1.0" encoding="utf-8"?> <sword:error xmlns:sword="http://purl.org/net/sword/error/" xmlns="http://www.w3.org/2005/Atom" href="http://purl.org/net/sword/error/ErrorBadRequest"> <title>ERROR</title> <updated>2023-05-18T02:06:47+02:00</updated> <author> <name>HAL SWORD API Server</name> </author> <source> <generator uri="https://api.archives-ouvertes.fr/sword" version="1.0">hal@ccsd.cnrs.fr</generator> </source> <summary>Some parameters sent with the request were not understood</summary> <sword:treatment>processing failed</sword:treatment> <sword:verboseDescription>{"mainmeta":{"mainDomain":{"isEmpty":"Cette valeur est obligatoire et ne peut \u00eatre vide"}}}</sword:verboseDescription> <link rel="alternate" href="https://api.archives-ouvertes.fr" type="text/html"/> </sword:error>
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccCC BYen_US
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Orphanet%20Journal%20of%20Rare%20Diseases&amp;rft.date=2022-12-23&amp;rft.volume=17&amp;rft.issue=1&amp;rft.spage=448-460&amp;rft.epage=448-460&amp;rft.eissn=1750-1172&amp;rft.issn=1750-1172&amp;rft.au=GUFFON,%20Nathalie&amp;GENEVAZ,%20Delphine&amp;LACOMBE,%20Didier&amp;LE%20PEILLET%20FEUILLET,%20Eliane&amp;BAUSSON,%20Pascale&amp;rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée